2014
DOI: 10.1245/s10434-014-3584-y
|View full text |Cite
|
Sign up to set email alerts
|

CD8+ and FOXP3+ Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer

Abstract: Favorable anticancer immunity occurred after CRT for rectal cancer by altering TIL subsets. A high CD8/FOXP3 IEL ratio before CRT and a high CD8+ STL density after CRT were associated with a favorable clinical outcome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

13
113
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 122 publications
(126 citation statements)
references
References 26 publications
13
113
0
Order By: Relevance
“…2). The majority support a positive impact on prognosis associated with extensive memory T-cell infiltration in the same cancers we discussed earlier, eg, CRC (Anitei et al, 2014;Boissi ere-Michot et al, 2014;Correale et al, 2012;Kim, Bae, et al, 2015;Ling et al, 2014;Ong et al, 2015;Shinto et al, 2014), bladder (Ingels et al, 2014), breast de Kruijf et al, 2013;García-Martínez et al, 2014;Kim et al, 2013;Mohammed et al, 2013;Park et al, 2012;Rathore et al, 2014;Seo et al, 2013;West et al, 2013), Merkel cell carcinoma (Paulson et al, 2014), glioma (Han et al, 2014), pancreatic (Ino et al, 2013;Tang et al, 2014), head and neck (Balermpas et al, 2014;Czystowska et al, 2013;Millrud et al, 2012;Wallis et al, 2015), cervical (Origoni et al, 2013), NSCLC Hald et al, 2013), gastric Feichtenbeiner et al, 2014;Kim et al, 2014), ovarian (Bachmayr-Heyda et al, 2013;Nielsen et al, 2012;Preston et al, 2013), and HCC (Cariani et al, 2012;Chen et al, 2012;Guo et al, 2007;Huang et al, 2012) (Table 1 and Fig. 2).…”
Section: Role Of T Cellssupporting
confidence: 65%
“…2). The majority support a positive impact on prognosis associated with extensive memory T-cell infiltration in the same cancers we discussed earlier, eg, CRC (Anitei et al, 2014;Boissi ere-Michot et al, 2014;Correale et al, 2012;Kim, Bae, et al, 2015;Ling et al, 2014;Ong et al, 2015;Shinto et al, 2014), bladder (Ingels et al, 2014), breast de Kruijf et al, 2013;García-Martínez et al, 2014;Kim et al, 2013;Mohammed et al, 2013;Park et al, 2012;Rathore et al, 2014;Seo et al, 2013;West et al, 2013), Merkel cell carcinoma (Paulson et al, 2014), glioma (Han et al, 2014), pancreatic (Ino et al, 2013;Tang et al, 2014), head and neck (Balermpas et al, 2014;Czystowska et al, 2013;Millrud et al, 2012;Wallis et al, 2015), cervical (Origoni et al, 2013), NSCLC Hald et al, 2013), gastric Feichtenbeiner et al, 2014;Kim et al, 2014), ovarian (Bachmayr-Heyda et al, 2013;Nielsen et al, 2012;Preston et al, 2013), and HCC (Cariani et al, 2012;Chen et al, 2012;Guo et al, 2007;Huang et al, 2012) (Table 1 and Fig. 2).…”
Section: Role Of T Cellssupporting
confidence: 65%
“…In rectal cancer, neoadjuvant radiotherapy may induce inflammation and immune cell infiltration. 41 We exclude a major impact here from since we could verify direct surgery without prior radiotherapy in 42 cases and use of neoadjuvant radiotherapy in only one case.…”
Section: Methodsmentioning
confidence: 99%
“…Scoring of intraepithelial lymphocytes (IELs) and stromal lymphocytes (STLs) was performed as previously reported [17]. CD8 + and FoxP3 + IELs were counted in the densest field using a ×40 objective lens.…”
Section: Immunohistochemistry For Til Scoringmentioning
confidence: 99%
“…Further, to elucidate whether keloid-like collagen and myxoid stroma observed in the resected surgical specimens belong to the original characteristics of the tumor or are newly formed features under the influence of CRT, we compared DR categories in the resected surgical specimens with histological features in pretreatment biopsy specimens. Given that DR categories are related to the density of tumor-infiltrating lymphocytes (TIL) [13,14], we investigated the density of CD8 + T cells and FoxP3 + T cells, a combination of representative populations of cytotoxic and regulatory T cells which reportedly characterize local antitumor immunity in various malignancies receiving neoadjuvant therapy [17][18][19].…”
Section: Introductionmentioning
confidence: 99%